Clinuvel Pharmaceuticals Limited (CUV) is a biopharmaceutical company focused on developing drugs for the treatment of a range of severe skin disorders. CUV’s lead compound is SCENESSE (afamelanotide), a drug targeting erythropoietic protoporphyria (EPP).
Clinuvel Pharmaceuticals Limited operators in Health Care sector and under industry of Biotechnology. The company website is: http://www.clinuvel.com.
The most recent CUV dividend details are as follows: ex-dividend date: 04/09/2019. This dividend is 2.5 cents. Franking percentage is: 0%. The payment date for this dividend is 19/09/2019.
Based on our analysis, from 2010, Clinuvel Pharmaceuticals Limited pays dividend 2 times. Total dividend is 4.5 cents. Average dividend is 2.25 cents. Maximum dividend is 2.5 cents while minimum dividend is 2 cents. We believe using more recent dividend history can provide better dividend analysis for a company.
You can also check out dividend history for similar stocks in the same sector as follows:
CUV Dividend Dates
Please click the table header to sort the data.
|Dividend||Franking||Ex-Dividend Date||Payment Date|
Dividend Growth Chart
A picture is better than thousands of words. The following chart shows you CUV dividend growth over the years